Glycorex Transplantation AB
Develops technology to remove antibodies, enabling organ transplants across blood groups.
GTAB | NGM
Overview
Corporate Details
- ISIN(s):
- SE0000524522 (+1 more)
- LEI:
- 549300BFHBYZ3X96EP25
- Country:
- Sweden
- Address:
- Scheelevägen 27, 223 63 Lund
- Website:
- https://glycorex.com/
- Sector:
- Manufacturing
Description
Glycorex Transplantation AB is a medical technology company that has developed a proprietary technology platform for the specific removal of antibodies from blood. The technology is based on biologically active carbohydrates for extracorporeal blood treatment. Its flagship product, Glycosorb® ABO, is a single-use medical device that enables organ transplantation across the blood group barrier, primarily for kidney, liver, heart, and stem cell transplants. Used clinically since 2001, the product has facilitated over 6,000 ABO-incompatible transplants with documented long-term results comparable to blood group compatible procedures. The company is leveraging its core technology to expand into new applications, including a product for creating universal blood plasma for transfusions and developing novel treatments for autoimmune diseases, with an initial focus on rheumatoid arthritis.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2022-05-03 08:00 |
Glycorex Transplantation (GTAB B): Kallelse till årsstämma 31 maj 2022
|
Swedish | PDF • 131.7 KB | ||
| 2022-04-29 15:59 | Swedish | ZIP • 13.0 MB | |||
| 2022-03-01 09:23 | Swedish | HTML • 13.5 KB | |||
| 2022-02-23 08:01 | Swedish | PDF • 10.3 MB | |||
| 2022-01-17 17:20 |
Glycorex Transplantation (GTAB B): Concludes agreement with distributor in Sout…
|
English | PDF • 130.6 KB | ||
| 2022-01-17 17:20 |
Glycorex Transplantation (GTAB B): Sluter avtal med distributör i Sydafrika
|
Swedish | PDF • 166.0 KB | ||
| 2021-11-24 08:00 | Swedish | PDF • 18.0 MB | |||
| 2021-11-02 16:35 |
Glycorex Transplantation AB: Geert Nygaard utsedd till ny VD
|
Swedish | PDF • 146.2 KB | ||
| 2021-11-02 16:35 |
Glycorex Transplantation AB: Geert Nygaard appointed as new CEO
|
English | PDF • 147.2 KB | ||
| 2021-10-25 13:05 |
Uppdatering kring prelanseringsplanen av UBP-produkten
|
Swedish | PDF • 170.6 KB | ||
| 2021-08-25 08:00 | English | PDF • 833.1 KB | |||
| 2021-06-23 19:10 |
Glycorex Transplantation AB (GTAB B): Uppdatering kring UBP-produkten
|
Swedish | PDF • 187.5 KB | ||
| 2021-06-15 19:15 |
Glycorex Transplantation AB (GTAB B): Pontus Nobréus lämnar rollen som verkstäl…
|
Swedish | PDF • 165.0 KB | ||
| 2021-06-08 13:15 |
Glycorex Transplantation AB (GTAB B): Årsstämman 8 juni 2021
|
Swedish | PDF • 184.0 KB | ||
| 2021-05-19 08:00 | Swedish | PDF • 587.5 KB |
Automate Your Workflow. Get a real-time feed of all Glycorex Transplantation AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Glycorex Transplantation AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Glycorex Transplantation AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
